Org chart
Mark A. Goldsmith
President, CEO & Board Chairman
Mark A. Goldsmith
Collapse
Wei Lin
Chief Medical Officer
Luan M. Wilfong
Chief Human Resources Officer
Daniel Simon
Chief Business Officer
Steve Kelsey
President, Research & Development
Adrian Gill
SVP, Medicinal Chemistry
Jan Smith
SVP, Biology
Jack Anders
SVP, Finance & Principal Accounting Officer
Alicia Gardner
SVP, Commercial
Shaoling Li
VP, CMC & Quality
Zhengping Wang
VP, Non-Clinical Development & Clinical Pharmacology
Jeff Cislini
VP & Deputy General Counsel
Pete Wildes
VP, Cancer Biology
Stephen Chan
VP, Clinical Data Management, Statistical Programming, & Clinical Systems
Robert Nichols
VP, Corporate Development
Linnet Zia
VP, Financial Planning & Analysis & Strategy
Tamara Kale
VP, Intellectual Property
Marieke Van Den Haak
VP, Program, Portfolio & Alliance Management
Bojena Bitman
VP, Quantitative Sciences
Sriram Naganathan
VP, Chemistry Manufacturing, & Controls
Zane Rogers
VP, Regulatory Affairs
Hieu le
Vice President, Compliance
Peg Horn
Chief Operating Officer
